Search results
1 – 4 of 4Sundaravalli Narayanaswami and N Ravichandran
Jarsh Safety received an order of 500 units of its Model S helmet. However, the order must be delivered within 15 days. Jarsh Safety was founded by three engineering college…
Abstract
Jarsh Safety received an order of 500 units of its Model S helmet. However, the order must be delivered within 15 days. Jarsh Safety was founded by three engineering college peers, who conceptualized air-conditioned, industrial safety helmets. This innovative revolutionary product offered industrial workers not only safety but aesthetics and comfort. The founders hoped that the product could change the perception of safety helmets from mandatory wear to desired wear. The case details the production process, staffing, raw material required and procurement lead time.
Details
Keywords
Sonal Sisodia and Nimit Chowdhary
Pharmaceutical marketing, brand protection.
Abstract
Subject area
Pharmaceutical marketing, brand protection.
Study level/applicability
It could be used with the pharmaceutical marketing students and MBA students for analysing counterfeit medicines' menace in developing countries and positioning of a disruptive technology. The case could be used for marketing consultants, Brand managers and executive development programmes to explore issues such as protecting brands through technology, pharmaceutical packaging marketing, competitiveness of counterfeit drugs, global harmonisation.
Case overview
Against the backdrop of rising menace of counterfeit drugs in developing countries, the case talks in particular about an innovative pharmaceutical packaging company. The company has developed a unique security technology called non-ClonableID™ which can enable products to be authenticated throughout the supply chain, thus protecting brands and preventing misuse. Despite a promising technology, it poses challenges regarding its adoption and commercial success.
Expected learning outcomes
Counterfeiting as an inevitable result of Globalization has become a global nuisance and has to be dealt at global level. Brand protection could be one of the lowest cost tools for pharmaceutical companies to restore public confidence in their products and themselves. While all methods for anti-counterfeiting are known to have short lives the menace still must be dealt with. For this, companies need to deploy anti-counterfeiting strategies that set up various layers of security.
Supplementary materials
Teaching note.
Details
Keywords
Xiangfeng Chen, Chuanjun Liu and Zhaolong Yang
In China, supply chain finance (SCF) has gradually emerged as a new service for the retail industry. This case systematically discusses how JD conducts product design and risk…
Abstract
In China, supply chain finance (SCF) has gradually emerged as a new service for the retail industry. This case systematically discusses how JD conducts product design and risk control of supply chain finance and related financial services, and analyze the impact of supply chain finance on JD's retail operations. The case also analyzes the relationship between JD supply chain finance and traditional financial institutions, and explore the future development of retail supply chain finance.
Robert F. Bruner and Derick Bulkley
This case is an abridged version of UVA-F-1115. This version is intended for use with audiences requiring less source documentation than is available in the unabridged version…
Abstract
This case is an abridged version of UVA-F-1115. This version is intended for use with audiences requiring less source documentation than is available in the unabridged version. The teaching note, however, contains all the source documentation in an appendix.
Details